SITC Archive Library

Back to Library

SITC 2017 Annual Meeting: Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors 

11-21-2017 11:31

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors" during the SITC 2017 Annual Meeting on November 10, 2017. Available here are the presentation slides and video from the session.

Program Organizers

  • Chair: Mario Sznol, MD – Yale School of Medicine
  • Charlie Garnett Benson, PhD – Georgia State University
  • Elizabeth A. Repasky, PhD – Roswell Park Cancer Institute

Program Summary

The Society for Immunotherapy of Cancer's (SITC) 32nd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. This session provided highlights of the latest achievements in the field of cancer immunotherapy as it relates to hematologic malignancies and solid tumors.

Intended Audience

The audience included U.S. and international researchers, regulators and healthcare professionals involved in cancer research and clinical care. This included, but was not limited to basic, translational and clinical researchers; postdoctoral fellows; oncologists; registered nurses; nurse practitioners; pharmacists; payers; and other allied health professionals.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#HematologicMalignancies#PresentationSlides#Video#AnnualMeeting#SITC
#AlliedHealth#Clinician#Industry#Researcher#2017#ClinicalTrials#Leukemia
#Myeloma#Melanoma#Vaccines

Statistics
0 Favorited
105 Views
6 Files
0 Shares
164 Downloads

​
Attachment(s)
Download All
pdf file
"Preclinical & Mouse Models" - Presentation Slides   15.93 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; Presenter: Matthew M. Gubin, PhD – Washington University School of Medicine; Date: November 10, 2017
 
Download
mp4 file
"Preclinical & Mouse Models" - Video   280.12 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; Presenter: Matthew M. Gubin, PhD – Washington University School of Medicine; Date: November 10, 2017
 
Download
pdf file
"Tumor Vaccines in AML" - Presentation Slides   5.01 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; Presenter: David E. Avigan, MD – Beth Israel Deaconess Medical Center; Date: November 10, 2017
 
Download
mp4 file
"Tumor Vaccines in AML" - Video   261.66 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; Presenter: David E. Avigan, MD – Beth Israel Deaconess Medical Center; Date: November 10, 2017
 
Download
pdf file
"Improvement in Epitope Discovery" - Presentation Slides   5.18 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; Presenter: Catherine J. Wu, MD – Dana-Farber Cancer Institute; Date: November 10, 2017
 
Download
mp4 file
"Improvement in Epitope Discovery" - Video   317.81 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 105: Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; Presenter: Catherine J. Wu, MD – Dana-Farber Cancer Institute; Date: November 10, 2017
 
Download